Creso Pharma is looking to increase revenue from nutraceuticals and animal health products as part of its renewed strategy. The ASX cannabis group expects to generate more than $3.6 million in revenue in CY 2019 from the segment.
Cost management was highlighted as a priority as Creso Pharma looks to reduce its monthly cash burn.
- Forums
- ASX - By Stock
- CPH
- Ann: Reinstatement to Official Quotation
Ann: Reinstatement to Official Quotation, page-22
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)